Vericel Corporation
Cambridge, MA, US· latest recorded location
Vericel Corporation is named on 5 US grants and 8 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 5
- Published applications
- 8
- Inventors
- 17
- Granted in 2026 so far
- 0
- Most recent grant
- 16 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 1 |
| 2016 | 1 | 0 |
| 2017 | 0 | 0 |
| 2018 | 1 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 2 | 1 |
| 2025 | 1 | 2 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 13 documents
Recent patents
- Compositions and methods for repairing cartilage defects16 Dec 2025US 12,496,317 B2
- Methods and devices for repairing cartilage defects2 Jan 2024US 11,857,170 B2
- Compositions and methods for repairing cartilage defects2 Jan 2024US 11,857,576 B2
- Cell seeding device and method3 Jul 2018US 10,011,811 B2
- Mixed cell populations for tissue repair and separation technique for cell processing16 Aug 2016US 9,415,071 B2
- Compositions and methods for repairing cartilage defects12 Mar 2026US 2026/0069637 A1
- Methods and devices for repairing cartilage defects22 May 2025US 2025/0161073 A1
- Methods for repairing cartilage defects2 Jan 2025US 2025/0000672 A1
- Compositions and methods for repairing cartilage defects4 Apr 2024US 2024/0108660 A1
- Methods and devices for repairing cartilage defects7 Sep 2023US 2023/0277163 A1
Most cited
By later US patents